Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanofi Teams With US Military On Zika, But Not For The Profits

Executive Summary

Sanofi Pasteur has entered into an agreement with the US Walter Reed Army Institute of Research, part of the Department of Defense, to develop a Zika vaccine. But the company said it's not doing it for any potential profits, but has a "moral imperative" to respond to the epidemic.


Related Content

Zika Vaccines Might Be Approved By 2020
Zika Vaccine Trials Could Test Multiple Candidates Vs. Common Control Group
Moderna's Valera Takes mRNA Approach To Combat Zika
NIH's Zika Vaccine Faces Funding Challenge After Skipping Industry Partnership
Fauci: Borrowed Cash Won't Carry Zika Efficacy Trials
Zika Funds Stuck In Political Fight; Vaccines Continue On Borrowed Cash
Congrats, Your Vaccine Works; Now, Who Will Buy It?


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts